Interesting MRI data to detect drug induced liver injury presented at ISMRM 2021

May 20th, 2021

At the ongoing 2021 International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting, Mikael Montelius (Imaging Specialist at Antaros Medical) and co-authors presented data on dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) to detect drug induced liver injury. The work originates from the Innovative Medicines Initiative TRISTAN consortium which aims to validate imaging biomarkers for drug safety assessments. Antaros Medical are proud partners of this collaborative project.

 

Find the presented data here:

Title: Acute and chronic rifampicin effect on gadoxetate uptake in rats using gadoxetate DCE-MRI

Session: Liver Function & Pancreas, D-19

Date and time: 19 May 2021, 13.00-14.00

Authors: Mikael Montelius, Steven Sourbron, Nicola Melillo, Daniel Scotcher, Aleksandra Galetin, Gunnar Schuetz, Claudia Green, Edvin Johansson, John C. Waterton, and Paul Hockings

Sign in required to read the full abstract.

 

The research leading to these results received funding from the Innovative Medicines Initiatives 2 Joint Undertaking under grant agreement No 116106. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

 

 

Back to all news